Paul Bisaro
Director, Myriad Genetics Inc; Director, Zoetis
Bought, 12 months
$0.2M
Sold, 12 months
$0.0M
Companies
2
Latest trade
May 14, 2026
Companies
Myriad Genetics IncDirector +$0.0M ZoetisDirector +$0.2MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

